Malaria elimination transmission and costing in the Asia-Pacific: developing an investment case (Publications)
Background: The Asia-Pacific region has made significant progress against malaria, reducing cases and deaths by over 50% between 2010 and 2015. These gains have been facilitated in part, by strong pol
Activity of novel oral formulations of albendazole and mebendazole against <em>Heligmosomoides polygyrus in vitro</em> and <em>in vivo</em> (Publications)
Albendazole (ABZ) and mebendazole (MBZ) are the two most commonly used drugs in the treatment of soil-transmitted helminths in humans but their performance is hampered by low solubility and physicoche
Assessing the effects of the nursing education reform on the educational environment in Tajikistan: a repeated cross-sectional analysis (Publications)
Background: A well-functioning education system for family nurses is a priority of the primary health care reform in Tajikistan. In 2015/2016, a baseline study was carried out to measure the education
Simulating the council-specific impact of anti-malaria interventions: a tool to support malaria strategic planning in Tanzania (Publications)
INTRODUCTION: The decision-making process for malaria control and elimination strategies has become more challenging. Interventions need to be targeted at council level to allow for changing malaria e
Dual plasmepsin-targeting antimalarial agents disrupt multiple stages of the malaria parasite life cycle (Publications)
Artemisin combination therapy (ACT) is the main treatment option for malaria, which is caused by the intracellular parasite Plasmodium. However, increased resistance to ACT highlights the importance o
TNF-α antagonists differentially induce TGF-β1-dependent resuscitation of dormant-like <em>Mycobacterium tuberculosis</em> (Publications)
TNF-alpha- as well as non-TNF-alpha-targeting biologics are prescribed to treat a variety of immune-mediated inflammatory disorders. The well-documented risk of tuberculosis progression associated wit
